Daicel Valuation Multiples

Discover Daicel's revenue and EBITDA valuation multiples and investment history, alongside public comparables like Turpaz Industries, OQ Base Industries, Verbio, Saudi Industrial Investment Group and more.

Daicel Overview

About Daicel

Daicel Corp is a Japanese chemical company engaged in engineering plastics, materials, medical health care, safety, smart materials, & other businesses. The company operates through five segments. The Engineering Plastics segment includes polyacetal resins, PET resins, liquid crystal polymers, and related products. The Material segment covers acetic acid, derivatives, acetate tow, cellulose acetate, and cosmetic raw materials. The Medical Health Care segment provides enantiomer separation columns and health food materials. The Safety segment offers inflators for automobile airbags and circuit breakers, while the Smart segment handles caprolactone derivatives, epoxy compounds, semiconductor materials, and functional films. The Others segment includes membranes and transportation warehouses.


Founded

1919

HQ

Japan

Employees

12.6K

Website

daicel.com

Financials (LTM)

Revenue: $3.7B
EBITDA: $533M

EV

$3.8B

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Daicel Financials

Daicel reported last 12-month revenue of $3.7B and EBITDA of $533M.

In the same LTM period, Daicel generated $951M in gross profit, $533M in EBITDA, and $104M in net income.


Daicel P&L

In the most recent fiscal year, Daicel reported revenue of $3.7B and EBITDA of $532M.

Daicel is profitable as of last fiscal year, with gross margin of 25%, EBITDA margin of 14%, and net margin of 2%.

See analyst estimates for Daicel
LTMLast FY202320242025202620272028
Revenue$3.7B$3.7B$3.4B$3.6B$3.6B
Gross Profit$951M$903M$962M$1B$931M
Gross Margin26%25%28%28%26%
EBITDA$533M$532M$651M$676M$504M
EBITDA Margin14%14%19%19%14%
EBIT Margin7%7%11%11%8%
Net Profit$104M$65M$321M$315M$123M
Net Margin3%2%9%9%3%
Net Debt-$1.5B---

Financial data powered by Morningstar, Inc.

Daicel Stock Performance

Daicel has current market cap of $2.3B, and enterprise value of $3.8B.


Daicel's stock price is $9.11.

Daicel share price increased by 7.7% in the last 30 days, and by 13.3% in the last year.

Daicel has an EPS (earnings per share) of $0.25.

See more trading valuation data for Daicel
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$3.8B$2.3B0.1%7.7%19.9%13.3%$0.25

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Daicel Valuation Multiples

Daicel trades at 1.0x EV/Revenue multiple, and 7.1x EV/EBITDA.

See NTM and 2027E valuation multiples for Daicel

Daicel Financial Valuation Multiples

As of July 17, 2026, Daicel has market cap of $2.3B and EV of $3.8B.

Daicel has a P/E ratio of 22.3x.

LTMLast FY202320242025202620272028
EV/Revenue1.0x1.0x1.1x1.1x1.1x
EV/EBITDA7.1x7.1x5.8x5.6x7.5x
EV/EBIT14.3x14.2x10.4x10.0x13.1x
EV/Gross Profit4.0x4.2x3.9x3.7x4.1x
P/E22.3x36.0x7.2x7.4x18.8x
EV/FCF31.4x29.6xn/m34.6x119.3x

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Daicel Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Daicel Margins & Growth Rates

Daicel grew revenue by 2% and EBITDA by 1% in the last fiscal year.

In the most recent fiscal year, Daicel reported gross margin of 25%, EBITDA margin of 14%, and net margin of 2%.

See estimated margins and future growth rates for Daicel

Daicel Margins

Last FY202420252026202720282029
Gross Margin25%28%26%26%
EBITDA Margin14%19%14%14%
EBIT Margin7%11%8%7%
Net Margin2%9%3%4%
FCF Margin3%3%1%2%

Daicel Growth Rates

FY+1/FY23/2424/2525/2626/2727/2828/29
Revenue Growth2%5%0%3%
Gross Profit Growth11%5%(8%)5%
EBITDA Growth1%4%(25%)2%
EBIT Growth(3%)5%(24%)(10%)
Net Profit Growth208%(2%)(61%)34%
FCF Growth(19%)(2914%)(71%)143%

Data powered by FactSet, Inc. and Morningstar, Inc.

Daicel Operational KPIs

Daicel's revenue per employee in the last FY averaged $0.3M, while opex per employee averaged $0.1M for the same period.

Daicel's Rule of 40 is 17% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Daicel's Rule of X is 22% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

Access forward-looking KPIs for Daicel
LTMLast FY202320242025202620272028
Rule of 4017%17%---
Bessemer Rule of X20%22%---
Revenue per Employee-$0.3M---
Opex per Employee-$0.1M---
R&D Expenses to Revenue4%4%--5%
Opex to Revenue-17%18%18%18%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Daicel Competitors

Daicel competitors include Turpaz Industries, OQ Base Industries, Verbio, Saudi Industrial Investment Group, MOPCO, Olin, Innospec, Saudi Kayan, Orbia and Huntsman.

Most Daicel public comparables operate across Chemicals and Packaging & Containers.

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
Turpaz Industries8.6x-37.7x-
OQ Base Industries4.6x4.2x10.4x10.5x
Verbio1.4x1.2x143.4x13.4x
Saudi Industrial Investment Group--(122.1x)23.7x
MOPCO3.4x2.9x5.9x5.1x
Olin0.8x0.8x8.6x8.7x
Innospec1.0x1.0x9.2x9.5x
Saudi Kayan2.0x2.1x23.3x19.1x

This data is available for Pro users. Sign up to see all Daicel competitors and their valuation data.

Start Free Trial

Investments by Daicel

Daicel has invested in 2 companies to date.

Latest investment by Daicel was on December 1st 2020. Daicel invested in PeptiStar in their $17M Strategic investment round (EV/Revenue multiple available to Pro users).

See VC round multiples

Latest Investments by Daicel

PeptiStar
Pi-Crystal
Description
PeptiStar is a Hangzhou-based CDMO specializing in peptide API manufacturing, including macrocycles, stapled peptides, and non-natural amino acids. The company provides end-to-end services from process development to commercial scale-up. Equipped with GMP facilities in China, PeptiStar serves global pharma clients with high-purity productions exceeding industry standards.
Pi-Crystal is an Osaka-headquartered subsidiary of Daicel Corporation founded in 2013 that develops printable organic semiconductor integrated circuits. The company manufactures high-mobility organic thin-film transistors and sensors using inkjet printing processes. Pi-Crystal supplies materials and devices for flexible electronics in wearables and IoT applications across Japan and Asia.
HQ CountryJapanJapan
HQ City
Settsu
Kashiwa
Deal Date1 Dec 20208 Jun 2018
RoundStrategic investmentStrategic investment
Raised$17M$500K
InvestorsAsahi Kasei; Daicel; Yokogawa Electric; Kobelco Eco-Solutions; YMCDaicel
Valuationundisclosedundisclosed
EV/Revenue
EV/EBITDA

This data is available for Pro users. Sign up to see all Daicel investments and their VC round multiples.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Daicel

When was Daicel founded?Daicel was founded in 1919.
Where is Daicel headquartered?Daicel is headquartered in Japan.
How many employees does Daicel have?As of today, Daicel has over 12K employees.
Is Daicel publicly listed?Yes, Daicel is a public company listed on Tokyo Stock Exchange.
What is the stock symbol of Daicel?Daicel trades under 4202 ticker.
When did Daicel go public?Daicel went public in 1949.
Who are competitors of Daicel?Daicel main competitors include Turpaz Industries, OQ Base Industries, Verbio, Saudi Industrial Investment Group, MOPCO, Olin, Innospec, Saudi Kayan, Orbia, Huntsman.
What is the current market cap of Daicel?Daicel's current market cap is $2.3B.
What is the current revenue of Daicel?Daicel's last 12 months revenue is $3.7B.
What is the current revenue growth of Daicel?Daicel revenue growth (NTM/LTM) is 2%.
What is the current EV/Revenue multiple of Daicel?Current revenue multiple of Daicel is 1.0x.
What is the current EBITDA of Daicel?Daicel's last 12 months EBITDA is $533M.
What is Daicel's EBITDA margin?Daicel's last 12 months EBITDA margin is 14%.
What is the current EV/EBITDA multiple of Daicel?Current EBITDA multiple of Daicel is 7.1x.
What is the current FCF of Daicel?Daicel's last 12 months FCF is $120M.
What is Daicel's FCF margin?Daicel's last 12 months FCF margin is 3%.
What is the current EV/FCF multiple of Daicel?Current FCF multiple of Daicel is 31.4x.
How many companies Daicel has acquired to date?Daicel hasn't acquired any companies yet (or none have been disclosed publicly).
In how many companies Daicel has invested to date?As of July 2026, Daicel has invested in 2 companies.

See public comps similar to Daicel

Lists including Daicel

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial